Work

Momelotinib's unique polypharmacology supports indication expansion beyond myelofibrosis

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-7853

Authors: Shane O'Brien, Henrik Hammarén, Bryan Strouse, Mary Antonysamy, Dwaipayan Patnaik, Hoang Tran, Anthony Mazurek, Michael McCabe

Institution: GlaxoSmithKline (United States)

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417010116

Cites:

Cited by:

Related to: